Scott Biller, Chief Scientific Officer at AGIOS PHARMACEUTICALS INC (AGIO), sold 4,500 shares at $75.70 ($342K) on 2018-02-05, disclosed to the SEC on 2018-02-07.
Open-market sale of $342k AGIO by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.89 | 799 | $60K | 17.5% |
| 2 | $74.89 | 799 | $60K | 17.5% |
| 3 | $75.70 | 1,100 | $83K | 24.4% |
| 4 | $76.76 | 701 | $54K | 15.7% |
| 5 | $76.76 | 701 | $54K | 15.7% |
| 6 | $78.03 | 400 |
| $31K |
| 9.1% |
| Total | $75.95 avg | 4,500 | $342K | 100% |
| Filing → |
| AGIO | SELL | 2019-03-01 | $585K | — | Filing → |
| AGIO | SELL | 2018-11-07 | $209K | — | Filing → |
| AGIO | SELL | 2018-10-09 | $277K | — | Filing → |